The final science report is now available for the CADTH project on Coagulation Factor IX FC Fusion Protein (Alprolix): Treatment Cost Comparison and Budget Impact Analysis.
The final report is now available for the CADTH project on: Comparative value of Erythrocyte Sedimentation Rate and C-Reactive Protein testing in combination versus alone for the diagnosis of undifferentiated patients with suspected inflammatory disease or serious infection: a systematic review…
The CADTH Lecture Series provides prominent scholars and opinion leaders with a forum to discuss pressing issues facing health technology assessment (HTA) and health care today.
We invite you to attend the next presentation in the CADTH Lecture Series. Health Technology Assessment: Then, Now, and…
A draft environmental scan document on Cancer Biomarker Testing is available for feedback from all interested stakeholders.
CADTH is pleased to announce the Student and Patient Group Representative Travel Award Programs for the 2016 CADTH Symposium, which will be held at the Shaw Centre in Ottawa, Ontario from April 10 to 12, 2016.
Applications for the Student Travel Award will be accepted from full-time undergraduate…
The list of included studies for the CADTH project Cognitive Processing Therapy for Post-Traumatic Stress Disorder is available for input from all interested stakeholders.
October 20, 2015, Ottawa, Ontario — Dr. Brian O’Rourke, President and CEO of CADTH, today announced that Maureen Trudeau, MD, FRCPC, has been appointed Chair (Elect) of the CADTH pCODR Expert Review Committee (pERC) for a six-month term beginning April 1, 2016. Dr. Trudeau will assume the role of…
CADTH invites interested individuals to propose topics for future CADTH Health Technology Assessment or Optimal Use projects.
We are specifically seeking topics related to medical devices, diagnostic testing, and medical, dental, and surgical procedures or programs that require information for pan-…
The draft science report for CADTH’s project on Anti–Vascular Endothelial Growth Factor Drugs for Retinal Conditions is now available for feedback from all interested stakeholders.
A draft Environmental Scan report on Positron Emission Tomography in Canada 2015 is available for feedback from all interested stakeholders.
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
CADTH is hosting a series of lectures by prominent scholars and opinion leaders to share their perspectives on some of the most pressing issues facing health technology assessment (HTA) and health care today.
We invite you to attend the next lecture which is being presented in partnership with the…